Antiretroviral Therapy and Viral Suppression Among Active Duty Service Members with Incident HIV Infection — United States, January 2012–June 2018
| Autor: | Jason F. Okulicz, Jason M Blaylock, Donald Shell, Shilpa Hakre, Brian K. Agan, Paul T. Scott, Shauna Stahlman, Todd Gleeson |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Medical surveillance Health (social science) Active duty Epidemiology Anti-HIV Agents Health Toxicology and Mutagenesis Military service Viremia HIV Infections 01 natural sciences 03 medical and health sciences Young Adult 0302 clinical medicine Health Information Management medicine Humans 030212 general & internal medicine Full Report 0101 mathematics Young adult business.industry Incidence (epidemiology) Incidence 010102 general mathematics General Medicine Middle Aged Viral Load medicine.disease United States Military personnel Military Personnel Treatment Outcome Emergency medicine Female business Viral load |
| Zdroj: | Morbidity and Mortality Weekly Report |
| ISSN: | 1545-861X 0149-2195 |
| Popis: | Human immunodeficiency virus (HIV) infection is a deployment-limiting medical condition for U.S. armed forces in the Department of Defense (DoD) (1). HIV management using contemporary antiretroviral therapy (ART) regimens permits effective suppression of viremia among persons in clinical care. Although service members with HIV infection can remain in military service, treatment outcomes have not been fully described. Data from the Defense Medical Surveillance System (DMSS) were analyzed to estimate ART use and viral suppression among DoD service members with diagnosed HIV infection during January 2012-June 2018 (2). Among 1,050 service members newly diagnosed with HIV infection during January 1, 2012-December 31, 2017, 89.4% received ART within 6 months of HIV diagnosis, 95.4% within 12 months, and 98.7% by the end of the surveillance period on June 30, 2018. Analyses determined that, among 793 persons who initiated ART and remained in military service for ≥1 year, 93.8% received continuous ART, 99.0% achieved viral suppression within 1 year after ART initiation, and 96.8% were virally suppressed at receipt of their last viral load test. The DoD model of HIV care demonstrates that service members with HIV infection who remain in care receive timely ART and can achieve both early and sustained viral suppression. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|